|Bid||68.46 x 100000|
|Ask||68.62 x 100000|
|Day's Range||67.32 - 69.42|
|52 Week Range||55.00 - 91.42|
|Beta (3Y Monthly)||1.25|
|PE Ratio (TTM)||10.82|
|Forward Dividend & Yield||1.06 (1.56%)|
|1y Target Est||N/A|
Germany's Fresenius Medical Care (FMC) said on Tuesday it had agreed to extend the deadline for its planned $2 billion takeover of U.S. home dialysis equipment maker NxStage Medical Inc until August 6. FMC said the extension had been agreed due to the recent U.S. government shutdown which interrupted the Federal Trade Commission's (FTC) ability to review the transaction.
MONMOUTH JUNCTION, N.J., Jan. 22, 2019 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced today that it has expanded its partnership with Fresenius Medical Care to Korea and Mexico. Under the terms of the agreement, Fresenius Medical Care has the exclusive rights to distribute CytoSorb for acute care and other hospital applications in Korea and Mexico.
Akorn said Wednesday ahead of the market open that the FDA sent a Jan. 4 warning letter tied to inspections of its Decatur, Illinois manufacturing facility that were conducted in April and May 2018. The FDA took exception to the company's failure to follow written procedures designed to prevent microbiological contamination of drug products, as well as a lack of control systems to prevent contamination and a written testing program to assess stability characteristics of drugs.
remains strategically well positioned with its online fashion platform and marketplace business model, analysts at Baader Helvea say on the heels of a two-day investor conference with Zalando. “We have the feeling that Zalando remains on track to reach our FY18E expectations,” the bank says. The Berlin-based online retailer could even become a potential takeover target at its current share price levels, Baader says, noting that Zalando is currently trading at a 35% discount to its closest rival Asos.
RICHMOND, Va. , Nov. 1, 2018 /PRNewswire/ -- Capital Square 1031, a leading sponsor of Delaware statutory trust investments, announced today that CS1031 Diversified Dialysis Portfolio, DST, comprised of ...
Germany's Fresenius Medical Care (FMEG.DE) (FMC) has identified measures to accelerate growth in its dialysis business but said weaker performance would continue in the fourth quarter. FMC cut its earnings target for the year in mid-October, citing slower growth in dialysis services in North America, its largest market. "We anticipate the impact from the current level of growth and less acquisitions to continue in the fourth quarter," Chief Executive Rice Powell said in a statement on Tuesday.
Germany's Fresenius (FREG.DE) said it was putting measures in place to improve growth at its dialysis and German hospitals businesses after a weaker performance of these units prompted the group to narrow its guidance earlier this month. Chief Executive Stefan Sturm said Fresenius's dialysis business, Fresenius Medical Care, and its German hospital chain would "enhance their efforts to further improve and adapt to changing market conditions". Earlier this month, Fresenius said it now expected net income to grow at the low end of the original 6 to 9 percent range, when adjusted for currency swings.
In this article, I will take a look at Fresenius Medical Care AG & Co KGaA’s (ETR:FME) most recent earnings update (30 June 2018) and compare these latest figures againstRead More...
The content of this article will benefit those of you who are starting to educate yourself about investing in the stock market and want to better understand how you canRead More...